Herbas VPB

Print
EN | LT
Supplementary protection
LT - Pakeisti oksazolidinonai ir jų panaudojimas kraujo krešėjimo srityje
EN - SUBSTITUTED OXAZOLIDINONES AND THEIR USE IN THE FIELD OF BLOOD COAGULATION
SPC
(11) Number of the document C 1261606
(68) Number of the document 1261606
(21) Application number for Supplementary Protection Certificate PA 2008 018
(22) Date of filing the application 2008-12-04
(41) Date of publication of the application 2009-01-26
Date of publication of SPC 2021-05-10
(24) Date of coming into effect of SPC 2020-12-12
Applicant
(71) Bayer HealthCare AG, 51368 Leverkusen, DE
Grantee
(73) Bayer Intellectual Property GmbH, Alfred-Nobel Strasse 50, 40789 Monheim am Rhein, DE
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/07/472/001 - EU/1/08/472/008, 2, 0008-09-30
Calculated date of expiry of the SPC
(94) 2023-10-02
Name of the product protected by the basic patent
(95) Rivaroxabanum
Paediatric extension
Request filed SPC extension granted until Request refused
2021-03-10 2024-04-02
Last renewal fee
Payment date Validity (years) Amount
2023-10-12 347.00 EUR
Legal status
SPC expired
Last update date 2024-04-09